REPLIGEN CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 2.43K shares.
- REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 31.32K shares, a 44.03% decline year-over-year.
- REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 20.00K shares, a 17.21% increase year-over-year.
- REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 78.07K shares, a 21.67% decline from fiscal 2024.
- REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 99.68K shares, a 147.89% increase from fiscal 2023.
- REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 40.21K shares, a 53.77% decline from fiscal 2022.
- REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 86.98K shares, a 11.63% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 2.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | 53.75K shares derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-06 | 51.32K shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 31.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 78.07K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 102.71K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 99.77K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 26.76K shares 10-Q · filed 2025-04-29 | 112.73K shares derived: sum of 4 quarters · filed 2025-04-29 |
| 2024-12-31 | 55.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | 99.68K shares 10-K · filed 2025-03-14 |
| 2024-09-30 | 17.06K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-18 | 61.06K shares derived: sum of 4 quarters · filed 2024-11-18 |
| 2024-06-30 | 12.95K shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | 62.22K shares derived: sum of 4 quarters · filed 2024-11-18 |
| 2024-03-31 | 13.71K shares 10-Q/A · filed 2024-11-18 | 52.62K shares derived: sum of 4 quarters · filed 2024-11-18 |
| 2023-12-31 | 17.34K shares derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-11-18 | 40.21K shares 10-K/A · filed 2024-11-18 |
| 2023-09-30 | 18.22K shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | 48.85K shares derived: sum of 4 quarters · filed 2024-11-18 |
| 2023-06-30 | 3.35K shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | 75.23K shares derived: sum of 4 quarters · filed 2024-11-18 |
| 2023-03-31 | 1.30K shares 10-Q/A · filed 2024-11-18 | 78.76K shares derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-12-31 | 25.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | 86.98K shares 10-K · filed 2023-02-22 |
| 2022-09-30 | 44.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 88.50K shares derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | 6.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 78.20K shares derived: sum of 4 quarters · filed 2022-08-02 |
| 2022-03-31 | 9.52K shares 10-Q · filed 2022-04-27 | 92.81K shares derived: sum of 4 quarters · filed 2022-04-27 |
| 2021-12-31 | 27.49K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | 98.43K shares 10-K · filed 2022-02-17 |
| 2021-09-30 | 34.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | 108.14K shares derived: sum of 4 quarters · filed 2021-10-28 |
| 2021-06-30 | 21.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | 130.81K shares derived: sum of 4 quarters · filed 2021-07-27 |
| 2021-03-31 | 15.14K shares 10-Q · filed 2021-05-04 | 287.81K shares derived: sum of 4 quarters · filed 2021-05-04 |
| 2020-12-31 | 37.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 340.55K shares 10-K · filed 2021-02-24 |
| 2020-09-30 | 56.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 307.70K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 178.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | 276.06K shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-03-31 | 67.88K shares 10-Q · filed 2020-05-06 | 153.65K shares derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | 4.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | 87.66K shares 10-K · filed 2020-02-26 |
| 2019-09-30 | 25.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 128.39K shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 56.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 138.56K shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 1.89K shares 10-Q · filed 2019-05-09 | 164.17K shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | 45.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 176.80K shares 10-K · filed 2019-03-01 |
| 2018-09-30 | 35.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 145.25K shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | 81.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 161.79K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 14.53K shares 10-Q · filed 2018-05-08 | 92.12K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 13.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | 215.50K shares 10-K · filed 2018-02-22 |
| 2017-09-30 | 52.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 163.29K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 12.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 245.85K shares derived: sum of 4 quarters · filed 2017-08-03 |
| 2017-03-31 | 137.90K shares 10-Q · filed 2017-05-04 | 291.02K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | -38.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 266.86K shares 10-K · filed 2017-02-23 |
| 2016-09-30 | 134.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 311.33K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 57.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 220.00K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 113.75K shares 10-Q · filed 2016-05-05 | 214.31K shares derived: sum of 4 quarters · filed 2016-05-05 |
| 2015-12-31 | 5.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 177.69K shares 10-K · filed 2016-02-25 |
| 2015-09-30 | 43.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 250.09K shares derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | 51.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 256.11K shares derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-31 | 77.13K shares 10-Q · filed 2015-05-08 | 662.92K shares derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | 78.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | 700.74K shares 10-K · filed 2015-03-17 |
| 2014-09-30 | 49.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | 665.24K shares derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | 458.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 714.64K shares derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | 114.94K shares 10-Q · filed 2014-05-09 | 732.30K shares derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | 42.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | 927.65K shares 10-K · filed 2014-03-14 |
| 2013-09-30 | 98.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | 1.07M shares derived: sum of 4 quarters · filed 2013-11-08 |
| 2013-06-30 | 475.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | 1.18M shares derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | 310.30K shares 10-Q · filed 2013-05-07 | |
| 2012-12-31 | 183.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | 609.40K shares 10-K · filed 2013-03-15 |
| 2012-09-30 | 208.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |